Clinical Trial Update: Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating tofacitinib for hospitalized acute severe ulcerative colitis management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: McMaster University | Conditions: Ulcerative Colitis Acute | Phase 2 | Status: ACTIVE_NOT_RECRUITING